Delivery Order SPE2DB25D9320-SPE2DB25FWEZK

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $6,597.90 contract covers the delivery of IOSAT 130 MG TABLET 14S, a pharmaceutical product, with a period of performance through April 2, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,466.20 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 27, 2024, is for the delivery of IOSAT 130 MG TABLET 14S, a pharmaceutical product. This award is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,027.10 firm fixed-price delivery order is for the supply of IOSAT 130 MG TABLET 14S, a pharmaceutical product, with an ultimate completion date of October 11, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $14,662.00 and an ultimate completion date of March 25, 2024. It is not a set-aside contract. The award is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with the DLA. This single-award vehicle allows the DLA to issue delivery orders...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The $1,466.20 firm fixed-price contract is for the delivery of IOSAT 130 MG TABLET 14S, with a completion date of February 13, 2024. The contract is not designated as a set-aside. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, contract 4600082013...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,996.50 firm fixed-price delivery order (SPE2DX25F6YXR) is for the provision of IOSAT 130 MG TABLET 14S, a specialized pharmaceutical product, with a period of performance through February 24, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,398.60 contract is for the delivery of IOSAT 130 MG TABLET 14S and has an August 22, 2023 completion date. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics...
The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order contract worth $13,708.97 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of IOSAT 130 MG TABLET 14S, with a completion date of February 12, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 under the SPE2DB program, which has a total potential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, from common medications to specialized...
This federal contract award is for the delivery of IOSAT 130 MG TABLET 14S, a pharmaceutical product, to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract, valued at $2,052.68, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order issued under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
  • SPE2DB25D9320
    Indefinite Delivery Contract
  • SPE2DB25D9320-SPE2DB25FWEZK
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $2,639.16, is for the delivery of IOSAT 130 MG TABLET 14S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025.

DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.

Generated 7/1/25, 8:32 AM